![John Neylan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Neylan
Director Técnico/Científico/I+D en
AKARI THERAPEUTICS, PLC
.
Perfil
John F.
Neylan is Chief Medical Officer & Executive Vice President at Akari Therapeutics Plc since 2022.
Formerly, Dr. Neylan was Chief Medical Officer & Senior Vice President at Angion Biomedica Corp.
from 2018 to 2022, Chief Medical Officer & Senior Vice President at Keryx Biopharmaceuticals, Inc. from 2015 to 2018, Vice President-Research & Development at Wyeth Research from 2000 to 2008, Director at Advances In Kidney Disease & Health, Senior Vice President-Clinical Development at Genzyme Corp., Professor at Emory University, Assistant Professor at the University of California, Davis, and President of The American Society of Transplantation.
Education includes undergraduate studies at Duke University and a doctorate from Rush Medical College.
Cargos activos de John Neylan
| Empresas | Cargo | Inicio |
|---|---|---|
| AKARI THERAPEUTICS, PLC | Director Técnico/Científico/I+D | 08/11/2022 |
Antiguos cargos conocidos de John Neylan.
| Empresas | Cargo | Fin |
|---|---|---|
| ANGN BIOM | Director Técnico/Científico/I+D | 15/08/2022 |
| KERYX BIOPHARMACEUTICALS | Director Técnico/Científico/I+D | 12/12/2018 |
Wyeth Research
 Wyeth Research Miscellaneous Commercial ServicesCommercial Services Discovers and develops platforms encompassing pharmaceuticals | Corporate Officer/Principal | 01/05/2008 |
Advances In Kidney Disease & Health
 Advances In Kidney Disease & Health Miscellaneous Commercial ServicesCommercial Services Provides awareness on kidney and urinary tract diseases | Director/Miembro de la Junta | - |
The American Society of Transplantation
 The American Society of Transplantation Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that provides transplantation and patient care services | Presidente | - |
Formación de John Neylan.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
56
Relaciones de 1er grado
11
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 11 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emory University
 Emory University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Advances In Kidney Disease & Health
Advances In Kidney Disease & Health Miscellaneous Commercial ServicesCommercial Services Provides awareness on kidney and urinary tract diseases | Commercial Services |
Wyeth Research
Wyeth Research Miscellaneous Commercial ServicesCommercial Services Discovers and develops platforms encompassing pharmaceuticals | Commercial Services |
The American Society of Transplantation
The American Society of Transplantation Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that provides transplantation and patient care services | Commercial Services |
Rush Medical College
 Rush Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Angion Biomedica Corp.
 Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products | Health Technology |
Akari Therapeutics Plc
 Akari Therapeutics Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for autoimmune and inflammatory diseases | Health Technology |
- Bolsa de valores
- Insiders
- John Neylan
